← Human Trials & Peer-Reviewed Studies
High-affinity growth hormone binding protein and acute heavy resistance exercise.
Plain-language guide to PMID 15741837 (2005): parallel-group controlled clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 15741837
- Journal
- Medicine and science in sports and exercise
- Year
- 2005
- Study type
- Controlled Clinical Trial
- Authors
- Rubin MR et al. (13 authors)
- DOI
- 10.1249/01.mss.0000155402.93987.c0
What This Study Did, in Plain Language
What Was Tested
This controlled clinical trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The purpose of this investigation was to examine the influence of resistance training on circulating concentrations of growth hormone binding protein (GHBP) in response to acute heavy resistance exercise.
Who Took Part
PubMed indexes the participants as adults, men only.
Using a cross-sectional experimental design, a group of resistance-trained men (RT, N=9, 7.9+/-1.3 yr resistance training experience) and a group of untrained men (UT, N=10) performed an acute heavy resistance exercise protocol (AHREP) consisting of 6 sets of 10 repetition maximum parallel squats.
How the Study Was Run
The design is described as parallel-group.
The Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group ran side by side rather than switching.
Blood samples were obtained 72 h before exercise, immediately before exercise, and 0, 15, 30, 45, and 60 min after exercise.
What Was Measured
The subject headings attached to it are Adaptation, Physiological, Blood Glucose, Carrier Proteins, Cross-Sectional Studies, Energy Intake, Exercise and Human Growth Hormone.
What This Means in Plain Language
The paper is a parallel-group study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The abstract goes on to report its results in about 8 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2005 (Medicine and science in sports and exercise), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.